Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia
Status:
Unknown status
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to gain initial safety and efficacy data on the experimental
agent REN-1654 in patients with painful post-herpetic neuralgia (PHN).